The 2021 BioRegion Report, promoted by Biocat with CataloniaBio & HealthTech and ACCIÓ, shows the sector’s evolution in a year marked by efforts in health innovation, and with European and global challenges in its sights.
This year of Biocat’s 15th anniversary brought a passing of the baton at the helm of the organization to Robert Fabregat. Learn more about his first months, the areas he wants to strengthen, how he imagines the BioRegion a few years from now, and his healthy habits
Catalonia is among the top 10 countries in Europe in terms of participation in clinical trials and among the top 20 in the world; looking at oncology alone, it is in the European Top 5 and the global Top 10. This November, Barcelona hosted the international Clinical Trials Europe event: a great time to look back over the factors that have made the BioRegion a benchmark in attracting trials from all the major pharmaceutical companies in the world, and also at the future challenges this sector is facing.
There is no shortage of talent in the BioRegion of Catalonia nor of research and innovation. Not in the most competitive sectors. As Captain Sparrow said, “The problem is not the problem. The problem is your attitude about the problem.” It is the production model that must change, and above all we have to stop saying we don’t know how to innovate.
One in four companies created in the BioRegion of Catalonia in the past five years is led by a woman. This percentage is growing, but still far from parity. Women call for greater public visibility so that other female researchers can see them as role models and choose to follow in their footsteps.
What do the biomedical sector and The Lord of the Rings have in common? Courage and a common goal are some of the traits shared by the main characters in this film saga, as well as by researchers, entrepreneurs, investors and other stakeholders who are helping make the BioRegion of Catalonia a benchmark in Europe.